Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3280 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2025-02-21 (pharmiweb.com)
Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Research Report Forecast to 2033 -
The Chemo Graded Nitrile Powder-free Medical Examination Gloves Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It provides key insights into production costs, market valuation, volume, and grow...
Read more
2025-01-13 (openpr.com)
Australia And New Zealand Cleanroom Gloves Market Detailed In New Research Report 2025 | Ansell Ltd., Kimberly-Clark Worldwide, Inc., Valutek Inc., Cardinal Health
Press release - Coherent Market Insights - Australia And New Zealand Cleanroom Gloves Market Detailed In New Research Report 2025 | Ansell Ltd., Kimberly-Clark Worldwide, Inc., Valutek Inc., Cardinal Health - published on openPR.com
Read more
2024-12-19 (quantisnow.com)
SEC Form DEF 14A filed by Becton Dickinson and Company
DEF 14A - BECTON DICKINSON & CO (0000010795) (Filer)
Read more
2024-10-04 (indiashorts.com)
Radiopharmaceuticals Market Size Projected to Soar to USD 16.6 Billion by 2032 with 10.4% CAGR – SNS Insider
According to Research by SNS Insider, The Radiopharmaceuticals Market growth is driven by advancements in nuclear medicine, personalized treatments, and rising demand for diagnostic imaging, the global radiopharmaceuticals market is set for robust ex
Read more
2024-10-01 (repertoiremag.com)
Cardinal Health’s RWE team completes FDA-funded research
September 30, 2024 – Cardinal Health’s Real-World Evidence and Insights team has completed research designed to advance the reliability of real-world evidence (RWE) for regulatory decision making. The research was funded by the U.S. Food and Drug Administration( FDA), which awarded the RWE team a$
Read more
2024-09-19 (offalyindependent.ie)
Speculation on EU funding support for Cardinal Health workers dampened
Minister for Further and Higher Education; Research; Innovation and Science, Patrick O’Donovan has moved to quell expectations that the 308 workers at Cardinal Health in Tullamore could be in line for funding support under the European Globalisation Adjus...
Read more
2024-09-17 (bignewsnetwork.com)
Biopsy Devices Market Size Worth $2.71 Billion By 2030: IndustryARC
Biopsy Devices Market Size Worth 271 Billion By 2030 IndustryARC
Read more
2024-03-08 (pharmacytimes.com)
Report: 2024 Projected to Be A Big Year for Biosimilars in the Retina Space
Cardinal Health released its 2024 biosimilars report, including research and in-depth analyses on legislative development, payer landscapes, and new treatments in the pipeline.
Read more
2024-01-19 (marketbeat.com)
MRP Capital Investments LLC Increases Holdings in Cardinal Health, Inc. (NYSE:CAH)
MRP Capital Investments LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 131.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 31,794 shares of the company's stock after purchasing an additional 18,059 shares during the pe
Read more
2023-10-23 (industrytoday.co.uk)
Medical Masks Market Research Report 2023: CAGR, Industry Needs, Competition Analysis
Medical Masks Market Research Report 2023: CAGR, Industry Needs, Competition Analysis
Read more
2023-10-19 (industrytoday.co.uk)
Global Skin Marker Pen Market Research Report 2023-2029
Global Skin Marker Pen Market Research Report 2023-2029
Read more
2023-06-10 (defenseworld.net)
Cardinal Health (NYSE:CAH) Hits New 12-Month High Following Analyst Upgrade
Cardinal Health, Inc. (NYSE:CAH – Get Rating) hit a new 52-week high during mid-day trading on Friday after Evercore ISI raised their price target on the stock from $90.00 to $95.00. The company traded as high as $87.10 and last traded at $87.04, with a volume of 1697385 shares changing hands.
Read more